eMolecules

San Diego, United States Founded: 2005 • Age: 21 yrs
Provider of an online search engine for uncharted chemical and biological for drug discovery

About eMolecules

eMolecules is a company based in San Diego (United States) founded in 2005. The company has 100 employees. eMolecules has completed 2 acquisitions, including Specs Compound Handling and Synple Chem. eMolecules offers products and services including Chemical Search Platform, Compound Reformatting, Building Blocks, Screening Compounds, and Custom Chemistry. eMolecules operates in a competitive market with competitors including ProQuest, ResearchGate, Authorea, Research Solutions and Mendeley, among others.

Key Metrics

Products & Services of eMolecules

eMolecules offers a comprehensive portfolio of products and services, including Chemical Search Platform, Compound Reformatting, Building Blocks, Screening Compounds, and Custom Chemistry.

Chemical Search Platform
Ecommerce

Platform for searching and ordering chemical compounds from suppliers.

Compound Reformatting
Service

Service for reformatting chemicals into required formats.

Building Blocks
Product

Catalog of chemical building blocks for research purposes.

Screening Compounds
Product

Collection of compounds for drug screening applications.

Custom Chemistry
Service

Tailored chemistry services for specific research needs.

Funding Insights of eMolecules

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of eMolecules with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2021–Private Equity Round–Avista Capital Partners
–
Valuation history

1 investors in total: 1 institutional.

Investors in eMolecules

eMolecules has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Avista Capital Partners.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity investments are focused on the United States market.
–avistacap.comNew York, United States
Premium access

Investor details for eMolecules

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of eMolecules

16 people are tracked at eMolecules (7 in leadership, 9 in team); the tracked headcount is 100.

NameRoleGroup
Niko Gubernator, Ph.D.
Chief Executive Officer, eMolecules Inc.Leadership
Janine Holmes
Vice President Human ResourcesLeadership
Anthony Calabria
VP Operations, Site LeadLeadership
Jeff Desroches
Senior Vice President, Corporate DevelopmentLeadership
Jeff Blazevich
Chief Financial OfficerLeadership
Larry Tang
Director of Supplier ManagementLeadership
David James
Senior Vice President Strategic Business DevelopmentLeadership
Elle O'Reilly
Staff AccountantTeam
Mra Page
Senior Laboratory/logistics Technician(dg Qualified)Team
Jolene Tate, CPA
ControllerTeam
Brennan Gregory
Supervisor, Supply Chain and Procurement OperationsTeam
Lester Marrison
SVP OperationsTeam
Scott T. Snyder
Svp, GM Compound ManagementTeam
Marvin Pagdanganan
Accounts Receivable SpecialistTeam
Paul Burke
Svp, GM Chemical Compound ProcurementTeam
Francisco Lopez
Operations AssociateTeam
Premium access

Complete people profiles for eMolecules

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by eMolecules

eMolecules has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Specs Compound Handling and Synple Chem.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Automated chemical synthesizers are developed using reagent capsules.
synplechem.comZurich, Switzerland2016Sep 2024β€’β€’β€’β€’
Contract research and compound management services are provided globally.
specs.netZoetermeer, Netherlands1987May 2023β€’β€’β€’β€’
Premium access

Complete acquisition details for eMolecules

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of eMolecules

4 dated milestones of eMolecules across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded eMolecules is founded.
  2. Funding First funding round.
  3. Acquisition Acquires Specs Compound Handling.
  4. Acquisition Acquires Synple Chem.

Competitors of eMolecules

eMolecules operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProQuest, ResearchGate, Authorea, Research Solutions and Mendeley, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
proquest.com2008Ann Arbor, United States––
Research content is delivered via online platforms to libraries.
researchgate.net2008Berlin, Germany$87.6M1
Online community for scientists
authorea.com2012New York, United States$2.11M88
Collaborative platform for research and learning
researchsolutions.com2006Henderson, United States$12.06M34
AI-powered solutions for scholarly content access and management are provided.
mendeley.com2007London, United Kingdom$6.6M–
Research management and collaboration are enabled via a web/mobile platform.
gcore.com2011Luxembourg$60M–
Collaborative learning and resource sharing for researchers are facilitated.
consensus.app2020Boston, United States$19.23M6
AI-enabled search tools for life sciences research are provided.
hypothes.is2011San Francisco, United States–55
An open annotation platform is offered for web-based discussions.
Premium access

Detailed competitors of eMolecules

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of eMolecules

The website of eMolecules (emolecules.com) receives about 20K visits a month.

  • Monthly visits
    20K

    ▼ 14.5% vs previous month

Similar websites

Websites whose visitors overlap most with eMolecules. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
chemspider.com
chemspider.com
100%
–#150,679–
chemdoodle.com
chemdoodle.com
100%
–#513,264–
rdchemicals.com
rdchemicals.com
99%
–#6,167,352–
chemexper.com
chemexper.com
98%
–#3,036,858–
chemsynthesis.com
92%
–#2,235,894View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 32 similar websites and full traffic analytics for eMolecules

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 32 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Emolecules

Premium access

Complete news archive for eMolecules

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to eMolecules

10 companies that operate in the same segment as eMolecules (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about eMolecules

eMolecules was founded in 2005 and raised its 1st funding round 16 years after it was founded.

eMolecules is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

eMolecules has 100 employees.

eMolecules was founded in 2005 in San Diego, United States. An online platform is operated by the company within the biotechnology sector, focusing on drug discovery. Services include a search engine that accesses uncharted chemical and biological compounds. Users are enabled to explore and source these materials for research purposes. The domain emolecules.com is utilized for operations, serving global pharmaceutical and research needs.

eMolecules's top competitors include ProQuest, ResearchGate and Research Solutions.

eMolecules offers Chemical Search Platform, Compound Reformatting, Building Blocks, Screening Compounds, and Custom Chemistry.

eMolecules has made 2 acquisitions, including Specs Compound Handling, and Synple Chem.

eMolecules has 1 investor. Key investors include Avista Capital Partners.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available